BetterScholar BetterScholar
16
Title Level Year L/Y
Role of tumor microenvironment in tumorigenesis
15 auth. Maonan Wang, Jing-zhou Zhao, Lishen Zhang, F. Wei, Yu Lian, Yingfen Wu, Zhaojian Gong, Shanshan Zhang, Jianda Zhou, K. Cao, ... Xiayu Li, W. Xiong, Gui-yuan Li, Zhaoyang Zeng, Can Guo
10 2017 10
2017
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai, Hongye Cheng, Zhonghu Bai, Jia Li
9 2017 9
2017
Nomogram Models for Predicting Risk and Prognosis of Newly Diagnosed Ovarian Cancer Patients with Liver Metastases - A Large Population-Based Real-World Study
8 auth. Gui-Min Hou, Chuang Jiang, Jin-peng Du, Chang Liu, Xiang-zheng Chen, Kefei Yuan, ... Hong Wu, Yong Zeng
9 2018 9
2018
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Xiaofeng Dai, Liangjian Xiang, Ting Li, Zhonghu Bai
8 2016 8
2016
Dendritic Cells in the Cancer Microenvironment
Yang Ma, G. Shurin, Peiyuan Zhu, M. Shurin
8 2012 8
2012
The Tumor Microenvironment Contribution to Development, Growth, Invasion and Metastasis of Head and Neck Squamous Cell Carcinomas
S. Koontongkaew
8 2013 8
2013
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Ruonan Yang, Q. Chang, Xianchun Meng, Nan Gao, Wan-Hai Wang
8 2018 8
2018
Current status and future directions of cancer immunotherapy
Hongming Zhang, Jibei Chen
8 2018 8
2018
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
Xun Chen, Ning Duan, Caiguo Zhang, Wentao Zhang
8 2016 8
2016
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
R. Divella, R. De Luca, I. Abbate, E. Naglieri, A. Daniele
8 2016 8
2016
Novel diagnostic biomarkers for prostate cancer
Chikezie O Madu, Yi Lu
8 2010 8
2010
HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature
J. T. Jørgensen, Maria Hersom
8 2012 8
2012
Comprehensive microRNA Profiling of Prostate Cancer
B. Walter, Vladimir A. Valera, P. Pinto, M. Merino
7 2013 7
2013
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
C. Costelloe, H. Chuang, J. Madewell, N. Ueno
7 2010 7
2010
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
Li-ting Guo, Haijun Zhang, Baoan Chen
7 2017 7
2017
Deep convolutional neural network VGG-16 model for differential diagnosing of papillary thyroid carcinomas in cytological images: a pilot study
9 auth. Qing Guan, Yunjun Wang, B. Ping, Duan-shu Li, Jiajun Du, Yu Qin, ... Hongtao Lu, Xiaochun Wan, J. Xiang
7 2019 7
2019